Ginkgo biloba L. extract enhances the effectiveness of syngeneic bone marrow mesenchymal stem cells in lowering blood glucose levels and reversing oxidative stress
- 493 Downloads
- 5 Citations
Abstract
Bone marrow mesenchymal stem cells (BMSCs) are potential therapy for diabetes. Owing to the oxidative stress caused by hyperglycemia, these transplanted BMSCs are with high rate of apoptotic death after transplantation. Ginkgo biloba L. extract (EGB) is a potent antioxidant which can remove free radicals. The study was to investigate whether EGB can protect BMSCs from oxidative stress in vitro and enhance the efficacy of BMSCs in lowering blood glucose levels after transplantation. BMSCs were cultured with H2O2, EGB, or H2O2 and EGB. Cell viability, malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and cell death rates were determined. Diabetes was induced by single injection of streptozotocin (STZ) in male Wistar rats. Diabetic rats received EGB, BMSCs, or EGB/BMSCs. The serum levels of glucose, insulin, interleukin 6 (IL-6), tumor necrosis factor α (TNF-α), MDA, SOD, and GSH-Px were determined. PKCα expression and NF-κB activation in kidney were determined. The MDA levels and cell death rates in BMSCs cultured with H2O2 and EGB were significantly lower; cell viability, SOD, and GSH-Px activities were significantly higher compared with those with H2O2 alone. Compared with diabetic rats receiving BMSCs, diabetic rats receiving EGB before BMSCs transplantation showed (1) significantly lower levels of blood glucose, serum MDA, IL-6, and TNF-α, and higher levels of insulin, SOD, and GSH-Px activities; (2) significantly lower PKCα expression and NF-κB activation in the kidney. EGB administration before BMSC transplantation can enhance the effectiveness of BMSCs in lowering blood glucose levels and reversing oxidative stress in diabetic rats.
Keywords
Bone marrow mesenchymal stem cells Ginkgo biloba L. extract Diabetes mellitus Antioxidant Oxidative stressNotes
Acknowledgments
We would like to thank Dr Lorann Stallones (Colorado Injury Control Research Center, Colorado State University) for revising the manuscript for us. This study was supported by the Department of Science and Technology of Jilin Province, China (Grant No 201105019).
Conflict of interest
The authors declare that there is no conflict of interest associated with this manuscript.
References
- 1.R.A. Kowluru, P.S. Chan, Oxidative stress and diabetic retinopathy. Exp. Diab. Res. (2007). doi: 10.1155/2007/43603
- 2.P.K. Mishra, S.R. Singh, I.G. Joshua, S.C. Tyagi, Stem cells as a therapeutic target for diabetes. Front. Biosci. 15, 461–477 (2010)PubMedCrossRefGoogle Scholar
- 3.L. Vija, D. Farge, J.F. Gautier, P. Vexiau, C. Dumitrache, A. Bourgarit et al., Mesenchymal stem cells: stem cell therapy perspectives for type 1 diabetes. Diabetes Metab. 35, 85–93 (2009)PubMedCrossRefGoogle Scholar
- 4.M. Mabed, M. Shahin, Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellitus. Curr. Stem Cell Res. Ther. 7(3), 179–190 (2012)PubMedCrossRefGoogle Scholar
- 5.J.H. Ho, T.C. Tseng, W.H. Ma, W.K. Ong, Y.F. Chen, M.H. Chen, M.W. Lin, C.Y. Hong, O.K. Lee, Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and beta cell differentiation in streptozosin-induced diabetic mice. Cell Transplant. (2011). doi: 10.3727/096368911X603611
- 6.Martin Rodriguez-Porcel, Olivier Gheysens, Ramasamy Paulmurugan, Ian Y. Chen, Karen M. Peterson, Jürgen K. Willmann et al., Antioxidants improve early survival of cardiomyoblasts after transplantation to the myocardium. Mol. Imaging Biol. 12, 325–334 (2010)PubMedCrossRefGoogle Scholar
- 7.Keisuke Ito, Atsushi Hirao, Fumio Arai, Keiyo Takubo, Sahoko Matsuoka, Kana Miyamoto et al., Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 12(4), 446–451 (2006)PubMedCrossRefGoogle Scholar
- 8.M.E.E. Shams, M.M.H. Al-Gayyar, E.A.M.E. Barakat, Type 2 diabetes mellitus-induced hyperglycemia in patients with NAFLD and normal LFTs: relationship to lipid profile, oxidative stress and pro-inflammatory cytokines. Sci. Pharm. 79, 623–634 (2011)PubMedCrossRefGoogle Scholar
- 9.M. Zeyda, T.M. Stulnig, Obesity, inflammation, and insulin resistance––a mini-review. Gerontology 55, 379–386 (2009)PubMedCrossRefGoogle Scholar
- 10.P.C. Chan, Q.S. Xia, P.P. FU, Ginkgo Biloba leave extract: biological, medicinal, and toxicological effects. J. Environ. Sci. Health C. 25, 211–244 (2007)Google Scholar
- 11.T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65(1–2), 55–63 (1983)PubMedCrossRefGoogle Scholar
- 12.D.G. Hafeman, R.A. Sunde, W.G. Hoekstra, Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J. Nutr. 104, 580–587 (1974)PubMedGoogle Scholar
- 13.K. Suzuki, B. Murtuza, J.R. Beauchamp, R.T. Smolenski, A. Varela-Carver, S. Fukushima et al., Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J. 18, 1153–1155 (2004)PubMedGoogle Scholar
- 14.X.H. Wu, C.P. Liu, K.F. Xu, X.D. Mao, J. Zhu, J.J. Jiang et al., Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells. World J. Gastroenterol. 13(24), 3342–3349 (2007)PubMedGoogle Scholar
- 15.M.F. El-Azab, F.M. Attia, A.M. El-Mowafy, Novel role of curcumin combined with bone marrow transplantation in reversing experimental diabetes: effects on pancreatic islet regeneration, oxidative stress, and inflammatory cytokines. Eur. J. Pharmacol. 658, 41–48 (2011)PubMedCrossRefGoogle Scholar
- 16.M. Valko, D. Leibfritz, J. Moncol, M.T.D. Cronin, M. Mazur, J. Telser, Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44–84 (2007)PubMedCrossRefGoogle Scholar
- 17.D.K. Singh, P. Winocour, K. Farrington, Oxidative stress in early diabetic nephropathy: fueling the fire. Nat. Rev. Endocrinol. 7, 176–184 (2011)PubMedCrossRefGoogle Scholar
- 18.C. Guijarro, J. Egido, Transcription factor-kB (NF-kB) and renal disease. Kidney Int. 59, 415–424 (2001)PubMedCrossRefGoogle Scholar
- 19.M. Romagnoli, M.C. Gomez-Cabrera, M.G. Perrelli, F. Biasi, F.V. Pallardó, J. Sastre, G. Poli, J. Viña, Xanthine oxidase-induced oxidative stress causes activation of NF-κB and inflammation in the liver of type I diabetic rats. Free Radic. Biol. Med. 49, 171–177 (2010)PubMedCrossRefGoogle Scholar